| Secondary |
| Bronchitis |
16.3% |
| Drug Use For Unknown Indication |
12.1% |
| Asthma |
8.9% |
| Influenza |
8.2% |
| Pneumonia |
8.2% |
| Upper Respiratory Tract Inflammation |
6.7% |
| Cough |
6.3% |
| Nasopharyngitis |
6.1% |
| Prophylaxis |
5.2% |
| Hypertension |
2.8% |
| Systemic Lupus Erythematosus |
2.8% |
| Bronchitis Acute |
2.6% |
| Hypercholesterolaemia |
2.6% |
| Diarrhoea |
1.7% |
| Nausea |
1.7% |
| Schizophrenia |
1.7% |
| Vomiting |
1.7% |
| Product Used For Unknown Indication |
1.5% |
| Back Pain |
1.3% |
| Diabetes Mellitus |
1.3% |
|
| Hepatitis Acute |
12.3% |
| Toxic Epidermal Necrolysis |
12.3% |
| Pneumonia |
7.7% |
| Pyrexia |
7.7% |
| Interstitial Lung Disease |
6.2% |
| Renal Failure Acute |
6.2% |
| Eosinophilic Pneumonia |
4.6% |
| Pneumonia Aspiration |
4.6% |
| Shock |
4.6% |
| Suicide Attempt |
4.6% |
| Urticaria |
4.6% |
| Drug Eruption |
3.1% |
| Erythema Multiforme |
3.1% |
| Hepatic Function Abnormal |
3.1% |
| Hypoglycaemic Coma |
3.1% |
| Renal Impairment |
3.1% |
| Somnolence |
3.1% |
| Tracheal Stenosis |
3.1% |
| Agranulocytosis |
1.5% |
| Alveolitis |
1.5% |
|
| Concomitant |
| Cough |
10.3% |
| Drug Use For Unknown Indication |
9.4% |
| Asthma |
8.2% |
| Prophylaxis |
7.1% |
| Nasopharyngitis |
7.0% |
| Influenza |
6.8% |
| Hypertension |
6.5% |
| Product Used For Unknown Indication |
5.9% |
| Bronchitis |
5.9% |
| Rheumatoid Arthritis |
5.5% |
| Upper Respiratory Tract Inflammation |
4.4% |
| Gastritis |
3.3% |
| Constipation |
3.2% |
| Pneumonia |
3.1% |
| Diabetes Mellitus |
2.9% |
| Insomnia |
2.8% |
| Pain |
2.2% |
| Cancer Pain |
2.1% |
| Interstitial Lung Disease |
1.9% |
| Pharyngitis |
1.6% |
|
| Interstitial Lung Disease |
10.0% |
| Pneumonia |
9.0% |
| Drug Exposure During Pregnancy |
6.8% |
| Vomiting |
6.5% |
| Abnormal Behaviour |
6.1% |
| Renal Impairment |
5.7% |
| White Blood Cell Count Decreased |
5.7% |
| Pneumothorax |
5.0% |
| Respiratory Failure |
4.7% |
| Tubulointerstitial Nephritis |
4.7% |
| Hallucination |
4.3% |
| Rash |
4.3% |
| Visual Acuity Reduced |
3.9% |
| Loss Of Consciousness |
3.6% |
| Platelet Count Decreased |
3.6% |
| Shock |
3.6% |
| Convulsion |
3.2% |
| Liver Disorder |
3.2% |
| Malaise |
3.2% |
| Delirium |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
17.8% |
| Angina Pectoris |
11.0% |
| Back Pain |
11.0% |
| Hypertension |
11.0% |
| Anxiety |
5.5% |
| Cardiac Pacemaker Insertion |
5.5% |
| Constipation |
5.5% |
| Dizziness |
5.5% |
| Hyperlipidaemia |
5.5% |
| Hyperuricaemia |
5.5% |
| Reflux Oesophagitis |
5.5% |
| Sick Sinus Syndrome |
5.5% |
| Upper Respiratory Tract Infection |
5.5% |
|
| Supraventricular Tachycardia |
100.0% |
|
